

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 6.00782490 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.72375103 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.45722921 |
| 4 | cell migration in hindbrain (GO:0021535) | 5.22780692 |
| 5 | neuromuscular process controlling posture (GO:0050884) | 5.12080211 |
| 6 | neurotransmitter secretion (GO:0007269) | 5.00138917 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.88588673 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.66217169 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.65747182 |
| 10 | glutamate secretion (GO:0014047) | 4.65126984 |
| 11 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.64869510 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.55038306 |
| 13 | neuromuscular synaptic transmission (GO:0007274) | 4.47321723 |
| 14 | detection of temperature stimulus (GO:0016048) | 4.41091380 |
| 15 | negative regulation of microtubule polymerization (GO:0031115) | 4.41062447 |
| 16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.39298998 |
| 17 | * axon cargo transport (GO:0008088) | 4.37108518 |
| 18 | neuronal ion channel clustering (GO:0045161) | 4.36613439 |
| 19 | nucleobase catabolic process (GO:0046113) | 4.35056343 |
| 20 | * intermediate filament organization (GO:0045109) | 4.31712202 |
| 21 | proline transport (GO:0015824) | 4.12254664 |
| 22 | axon development (GO:0061564) | 4.09643202 |
| 23 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.07531303 |
| 24 | cell communication by electrical coupling (GO:0010644) | 4.06593905 |
| 25 | presynaptic membrane organization (GO:0097090) | 4.01776239 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.01531931 |
| 27 | mitochondrion transport along microtubule (GO:0047497) | 4.01165987 |
| 28 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.01165987 |
| 29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.99888718 |
| 30 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.98533527 |
| 31 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.98533527 |
| 32 | establishment of mitochondrion localization (GO:0051654) | 3.98390011 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.97810100 |
| 34 | behavioral response to nicotine (GO:0035095) | 3.95210973 |
| 35 | protein localization to synapse (GO:0035418) | 3.95166419 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.93287418 |
| 37 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.91013955 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.90365956 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 3.89797425 |
| 40 | membrane depolarization during action potential (GO:0086010) | 3.89539819 |
| 41 | activation of protein kinase A activity (GO:0034199) | 3.81617728 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.80911114 |
| 43 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.77377280 |
| 44 | sodium ion export (GO:0071436) | 3.76900904 |
| 45 | neurotransmitter transport (GO:0006836) | 3.76662239 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.76251488 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 3.76005628 |
| 48 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.73881621 |
| 49 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.73881621 |
| 50 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.71922902 |
| 51 | auditory behavior (GO:0031223) | 3.71613397 |
| 52 | neuronal action potential (GO:0019228) | 3.66814338 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 3.59691262 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.57924728 |
| 55 | regulation of neurotransmitter levels (GO:0001505) | 3.54259792 |
| 56 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.54158811 |
| 57 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.50024581 |
| 58 | cell communication involved in cardiac conduction (GO:0086065) | 3.49035730 |
| 59 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.47425866 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.47225889 |
| 61 | locomotory exploration behavior (GO:0035641) | 3.45256194 |
| 62 | anterograde axon cargo transport (GO:0008089) | 3.44892185 |
| 63 | cell differentiation in hindbrain (GO:0021533) | 3.43764761 |
| 64 | negative regulation of dendrite development (GO:2000171) | 3.43160965 |
| 65 | organelle transport along microtubule (GO:0072384) | 3.42491194 |
| 66 | plasma membrane repair (GO:0001778) | 3.41736902 |
| 67 | innervation (GO:0060384) | 3.41060753 |
| 68 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.39996875 |
| 69 | synapse assembly (GO:0007416) | 3.39358298 |
| 70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.38041462 |
| 71 | neuromuscular process (GO:0050905) | 3.37752026 |
| 72 | glutamate receptor signaling pathway (GO:0007215) | 3.34409271 |
| 73 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.34126167 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.33499746 |
| 75 | positive regulation of potassium ion transport (GO:0043268) | 3.32660546 |
| 76 | exploration behavior (GO:0035640) | 3.29722092 |
| 77 | * intermediate filament cytoskeleton organization (GO:0045104) | 3.27746482 |
| 78 | axon extension (GO:0048675) | 3.27552625 |
| 79 | layer formation in cerebral cortex (GO:0021819) | 3.27110212 |
| 80 | presynaptic membrane assembly (GO:0097105) | 3.26903492 |
| 81 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.24580565 |
| 82 | forebrain neuron differentiation (GO:0021879) | 3.24376147 |
| 83 | * intermediate filament-based process (GO:0045103) | 3.23517630 |
| 84 | vocalization behavior (GO:0071625) | 3.22695271 |
| 85 | body morphogenesis (GO:0010171) | 3.21107963 |
| 86 | regulation of postsynaptic membrane potential (GO:0060078) | 3.20426410 |
| 87 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.18617225 |
| 88 | L-amino acid import (GO:0043092) | 3.17447984 |
| 89 | axon regeneration (GO:0031103) | 3.17070720 |
| 90 | adult walking behavior (GO:0007628) | 3.16732458 |
| 91 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.15496487 |
| 92 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.15218045 |
| 93 | embryonic body morphogenesis (GO:0010172) | 3.13357021 |
| 94 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.13226250 |
| 95 | vesicle transport along microtubule (GO:0047496) | 3.12784659 |
| 96 | response to auditory stimulus (GO:0010996) | 3.12590473 |
| 97 | retinal ganglion cell axon guidance (GO:0031290) | 3.09751999 |
| 98 | calcium ion-dependent exocytosis (GO:0017156) | 3.08798190 |
| 99 | cerebellar granule cell differentiation (GO:0021707) | 3.07803455 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 3.07671631 |
| 101 | positive regulation of neurotransmitter transport (GO:0051590) | 3.06409761 |
| 102 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.05832057 |
| 103 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05643423 |
| 104 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.05641294 |
| 105 | spinal cord association neuron differentiation (GO:0021527) | 3.05561272 |
| 106 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04767999 |
| 107 | response to acidic pH (GO:0010447) | 3.02683033 |
| 108 | positive regulation of axon extension (GO:0045773) | 3.02422733 |
| 109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01520624 |
| 110 | behavioral response to cocaine (GO:0048148) | 3.00392769 |
| 111 | glycine transport (GO:0015816) | 3.00335120 |
| 112 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.00271124 |
| 113 | positive regulation of axonogenesis (GO:0050772) | 3.00148252 |
| 114 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.98980708 |
| 115 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.98295316 |
| 116 | mechanosensory behavior (GO:0007638) | 2.97396090 |
| 117 | response to histamine (GO:0034776) | 2.97320398 |
| 118 | positive regulation of fibroblast migration (GO:0010763) | 2.95582351 |
| 119 | short-term memory (GO:0007614) | 2.90204737 |
| 120 | dendrite morphogenesis (GO:0048813) | 2.90177011 |
| 121 | axon ensheathment in central nervous system (GO:0032291) | 2.88687292 |
| 122 | central nervous system myelination (GO:0022010) | 2.88687292 |
| 123 | synapse organization (GO:0050808) | 2.88123401 |
| 124 | membrane repolarization during action potential (GO:0086011) | 2.87663570 |
| 125 | cerebellar Purkinje cell layer development (GO:0021680) | 2.87542638 |
| 126 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.87138715 |
| 127 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.86187915 |
| 128 | dopamine receptor signaling pathway (GO:0007212) | 2.86178290 |
| 129 | membrane hyperpolarization (GO:0060081) | 2.86078369 |
| 130 | positive regulation of membrane potential (GO:0045838) | 2.85713487 |
| 131 | neuron projection extension (GO:1990138) | 2.85003752 |
| 132 | * microtubule-based transport (GO:0010970) | 2.84001856 |
| 133 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.83909067 |
| 134 | axonal fasciculation (GO:0007413) | 2.83323063 |
| 135 | neuron recognition (GO:0008038) | 2.82768886 |
| 136 | membrane depolarization (GO:0051899) | 2.82519699 |
| 137 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.82098436 |
| 138 | regulation of axon extension (GO:0030516) | 2.81945817 |
| 139 | membrane repolarization (GO:0086009) | 2.81812158 |
| 140 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.81713505 |
| 141 | regulation of translational termination (GO:0006449) | 2.81266158 |
| 142 | * cytoskeleton-dependent intracellular transport (GO:0030705) | 2.80904383 |
| 143 | regulation of synapse structural plasticity (GO:0051823) | 2.79433737 |
| 144 | transmission of nerve impulse (GO:0019226) | 2.78771473 |
| 145 | signal release (GO:0023061) | 2.78014120 |
| 146 | synaptic transmission (GO:0007268) | 2.74992256 |
| 147 | regulation of neurotransmitter secretion (GO:0046928) | 2.70725270 |
| 148 | * regulation of axonogenesis (GO:0050770) | 2.70175202 |
| 149 | potassium ion homeostasis (GO:0055075) | 2.69014274 |
| 150 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.68755217 |
| 151 | mating behavior (GO:0007617) | 2.68298167 |
| 152 | * neurofilament cytoskeleton organization (GO:0060052) | 10.4545551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.62659812 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.45589088 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.34253076 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.27416576 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09742080 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02485010 |
| 7 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.97961376 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.89423061 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.89423061 |
| 10 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81061633 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.79975963 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.69614237 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.65913039 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46992438 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45780741 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44605918 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39768031 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.35572360 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35235831 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.33639017 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28121160 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24150223 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.19853938 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07972493 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03914381 |
| 26 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.03746746 |
| 27 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02384914 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01578942 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.99825520 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93497713 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.84177056 |
| 32 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.75500523 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71366217 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69524812 |
| 35 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69500278 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68634199 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60446542 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59231675 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57657226 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53921556 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52595900 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51541843 |
| 43 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.51368547 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50920314 |
| 45 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.44006727 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41240599 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35438104 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34882615 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33576584 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30518982 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29935891 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29430538 |
| 53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26431993 |
| 54 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21312820 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21080220 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19547882 |
| 57 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.18556946 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18349065 |
| 59 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17945799 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15734331 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15567708 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14186821 |
| 63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14186517 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11416888 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10999007 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10775815 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10180580 |
| 68 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.08357208 |
| 69 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08356934 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07808241 |
| 71 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07534068 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05594777 |
| 73 | * AR_19668381_ChIP-Seq_PC3_Human | 1.05465442 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05273981 |
| 75 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05115137 |
| 76 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04807620 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02456863 |
| 78 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.01913059 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00948424 |
| 80 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00660977 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99420471 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98960657 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98802572 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98529625 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97709741 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97090667 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97090667 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96969775 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96351065 |
| 90 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96260724 |
| 91 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94979957 |
| 92 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94568302 |
| 93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92751135 |
| 94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92343276 |
| 95 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91927684 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89591690 |
| 97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89328388 |
| 98 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88923795 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87012956 |
| 100 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86682981 |
| 101 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86519607 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84976580 |
| 103 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84821980 |
| 104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.83643245 |
| 105 | FUS_26573619_Chip-Seq_HEK293_Human | 0.83416100 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83252087 |
| 107 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83112232 |
| 108 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82881843 |
| 109 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82830809 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81993641 |
| 111 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.81976587 |
| 112 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81779543 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81777554 |
| 114 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81369645 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.80825237 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80382131 |
| 117 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.79857552 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.79813575 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79449280 |
| 120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79054655 |
| 121 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.78319919 |
| 122 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77957266 |
| 123 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75270593 |
| 124 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.74899540 |
| 125 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.74730149 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71353670 |
| 127 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.68252320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 4.77226425 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.58065508 |
| 3 | MP0004270_analgesia | 4.27025361 |
| 4 | MP0001968_abnormal_touch/_nociception | 4.16497604 |
| 5 | MP0003880_abnormal_central_pattern | 4.09776036 |
| 6 | MP0002736_abnormal_nociception_after | 3.78969441 |
| 7 | MP0004858_abnormal_nervous_system | 3.63003603 |
| 8 | MP0006276_abnormal_autonomic_nervous | 3.58000478 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 3.52196908 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.34199661 |
| 11 | MP0002733_abnormal_thermal_nociception | 3.13508929 |
| 12 | MP0009046_muscle_twitch | 3.13446807 |
| 13 | MP0002184_abnormal_innervation | 2.79894510 |
| 14 | MP0001970_abnormal_pain_threshold | 2.78890050 |
| 15 | MP0003123_paternal_imprinting | 2.71512223 |
| 16 | MP0004142_abnormal_muscle_tone | 2.69711394 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.62644488 |
| 18 | * MP0002272_abnormal_nervous_system | 2.59583925 |
| 19 | MP0001188_hyperpigmentation | 2.58033810 |
| 20 | MP0002064_seizures | 2.56475582 |
| 21 | MP0009745_abnormal_behavioral_response | 2.54151760 |
| 22 | MP0002063_abnormal_learning/memory/cond | 2.41468812 |
| 23 | * MP0000955_abnormal_spinal_cord | 2.39510713 |
| 24 | MP0003329_amyloid_beta_deposits | 2.31370983 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.22945563 |
| 26 | MP0001486_abnormal_startle_reflex | 2.11625970 |
| 27 | * MP0004811_abnormal_neuron_physiology | 1.99427532 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.94042790 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.93242377 |
| 30 | MP0008569_lethality_at_weaning | 1.75980274 |
| 31 | MP0000778_abnormal_nervous_system | 1.75187433 |
| 32 | MP0003121_genomic_imprinting | 1.69929640 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.67987952 |
| 34 | * MP0002882_abnormal_neuron_morphology | 1.60771641 |
| 35 | MP0004147_increased_porphyrin_level | 1.56886470 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.56716262 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.55607489 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.50111768 |
| 39 | MP0004924_abnormal_behavior | 1.48429904 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.48429904 |
| 41 | MP0002751_abnormal_autonomic_nervous | 1.47483113 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.42367720 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.41796200 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.40490907 |
| 45 | MP0003633_abnormal_nervous_system | 1.40387649 |
| 46 | MP0000751_myopathy | 1.40070933 |
| 47 | * MP0002229_neurodegeneration | 1.37846956 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.34979102 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.34524273 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.25606101 |
| 51 | * MP0002752_abnormal_somatic_nervous | 1.20093168 |
| 52 | MP0000604_amyloidosis | 1.19192744 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.18957376 |
| 54 | MP0001299_abnormal_eye_distance/ | 1.18893617 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.17811372 |
| 56 | MP0004133_heterotaxia | 1.16696911 |
| 57 | MP0003631_nervous_system_phenotype | 1.15060774 |
| 58 | MP0003879_abnormal_hair_cell | 1.14118655 |
| 59 | MP0001529_abnormal_vocalization | 1.13781671 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.13105430 |
| 61 | MP0005499_abnormal_olfactory_system | 1.13105430 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.12954066 |
| 63 | MP0003634_abnormal_glial_cell | 1.11888608 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.10659616 |
| 65 | MP0003385_abnormal_body_wall | 1.08696626 |
| 66 | MP0002163_abnormal_gland_morphology | 1.05909836 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.02986057 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.00575238 |
| 69 | MP0000920_abnormal_myelination | 1.00557080 |
| 70 | MP0003122_maternal_imprinting | 0.99310694 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 0.98192054 |
| 72 | MP0001984_abnormal_olfaction | 0.96925888 |
| 73 | MP0002269_muscular_atrophy | 0.92662655 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.92363678 |
| 75 | MP0005409_darkened_coat_color | 0.92356390 |
| 76 | MP0001963_abnormal_hearing_physiology | 0.89239530 |
| 77 | MP0005083_abnormal_biliary_tract | 0.88658992 |
| 78 | MP0004134_abnormal_chest_morphology | 0.87394039 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.85565252 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.85057298 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.84440222 |
| 82 | MP0003890_abnormal_embryonic-extraembry | 0.81016082 |
| 83 | MP0002152_abnormal_brain_morphology | 0.79729259 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 0.79532930 |
| 85 | MP0004885_abnormal_endolymph | 0.79173681 |
| 86 | MP0000747_muscle_weakness | 0.78469274 |
| 87 | MP0003119_abnormal_digestive_system | 0.78263234 |
| 88 | MP0003942_abnormal_urinary_system | 0.78177033 |
| 89 | MP0000538_abnormal_urinary_bladder | 0.76732436 |
| 90 | MP0003283_abnormal_digestive_organ | 0.73922783 |
| 91 | MP0004085_abnormal_heartbeat | 0.73325537 |
| 92 | MP0002822_catalepsy | 0.73072489 |
| 93 | MP0003011_delayed_dark_adaptation | 0.72491463 |
| 94 | MP0004742_abnormal_vestibular_system | 0.71855348 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.71739973 |
| 96 | MP0000026_abnormal_inner_ear | 0.71514990 |
| 97 | MP0002928_abnormal_bile_duct | 0.71318944 |
| 98 | MP0003938_abnormal_ear_development | 0.71098416 |
| 99 | MP0002160_abnormal_reproductive_system | 0.70056606 |
| 100 | MP0002081_perinatal_lethality | 0.70008697 |
| 101 | MP0003632_abnormal_nervous_system | 0.69904531 |
| 102 | MP0005645_abnormal_hypothalamus_physiol | 0.67177551 |
| 103 | MP0008872_abnormal_physiological_respon | 0.67125990 |
| 104 | MP0001270_distended_abdomen | 0.66823521 |
| 105 | MP0006292_abnormal_olfactory_placode | 0.65829046 |
| 106 | MP0005187_abnormal_penis_morphology | 0.65347454 |
| 107 | MP0001943_abnormal_respiration | 0.65315549 |
| 108 | MP0005195_abnormal_posterior_eye | 0.63583835 |
| 109 | MP0000566_synostosis | 0.63507129 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.62778998 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.62716873 |
| 112 | MP0001905_abnormal_dopamine_level | 0.62300312 |
| 113 | MP0008874_decreased_physiological_sensi | 0.60929674 |
| 114 | MP0000749_muscle_degeneration | 0.60836737 |
| 115 | MP0000759_abnormal_skeletal_muscle | 0.60181429 |
| 116 | MP0005535_abnormal_body_temperature | 0.59720066 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.55846013 |
| 118 | MP0002069_abnormal_eating/drinking_beha | 0.55819798 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.52961274 |
| 120 | MP0001664_abnormal_digestion | 0.51435054 |
| 121 | MP0005410_abnormal_fertilization | 0.50839296 |
| 122 | MP0010769_abnormal_survival | 0.50172625 |
| 123 | MP0010770_preweaning_lethality | 0.49465744 |
| 124 | MP0002082_postnatal_lethality | 0.49465744 |
| 125 | MP0004036_abnormal_muscle_relaxation | 0.47687036 |
| 126 | MP0010386_abnormal_urinary_bladder | 0.47395822 |
| 127 | MP0004233_abnormal_muscle_weight | 0.47300028 |
| 128 | MP0000569_abnormal_digit_pigmentation | 0.46314635 |
| 129 | MP0010768_mortality/aging | 0.45906209 |
| 130 | * MP0003861_abnormal_nervous_system | 0.44780195 |
| 131 | MP0004883_abnormal_blood_vessel | 0.44650036 |
| 132 | MP0003956_abnormal_body_size | 0.44353005 |
| 133 | MP0001177_atelectasis | 0.43389105 |
| 134 | MP0003787_abnormal_imprinting | 0.43195849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 9.08347086 |
| 2 | Myokymia (HP:0002411) | 7.58793398 |
| 3 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.69827448 |
| 4 | Supranuclear gaze palsy (HP:0000605) | 5.39970055 |
| 5 | Action tremor (HP:0002345) | 5.07573253 |
| 6 | Pheochromocytoma (HP:0002666) | 5.06891735 |
| 7 | Neuroendocrine neoplasm (HP:0100634) | 4.51290836 |
| 8 | Focal motor seizures (HP:0011153) | 4.29480294 |
| 9 | Hammertoe (HP:0001765) | 4.26085118 |
| 10 | Termporal pattern (HP:0011008) | 4.20215424 |
| 11 | Insidious onset (HP:0003587) | 4.20215424 |
| 12 | Focal seizures (HP:0007359) | 4.11312684 |
| 13 | Limb dystonia (HP:0002451) | 4.04466613 |
| 14 | Foot dorsiflexor weakness (HP:0009027) | 4.04160921 |
| 15 | Atonic seizures (HP:0010819) | 4.01985574 |
| 16 | Steppage gait (HP:0003376) | 3.97534054 |
| 17 | Febrile seizures (HP:0002373) | 3.81621071 |
| 18 | Ankle clonus (HP:0011448) | 3.76490569 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.73725768 |
| 20 | Abnormality of the foot musculature (HP:0001436) | 3.66387713 |
| 21 | Abnormality of the vocal cords (HP:0008777) | 3.64518130 |
| 22 | Onion bulb formation (HP:0003383) | 3.43349701 |
| 23 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.41751121 |
| 24 | Decreased motor nerve conduction velocity (HP:0003431) | 3.37258940 |
| 25 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.15223131 |
| 26 | Visual hallucinations (HP:0002367) | 3.12110732 |
| 27 | Urinary urgency (HP:0000012) | 3.11876321 |
| 28 | Distal sensory impairment (HP:0002936) | 3.08990395 |
| 29 | Hepatoblastoma (HP:0002884) | 3.07489131 |
| 30 | Failure to thrive in infancy (HP:0001531) | 3.05386980 |
| 31 | Ventricular fibrillation (HP:0001663) | 3.02658512 |
| 32 | Polyphagia (HP:0002591) | 2.99551023 |
| 33 | Absence seizures (HP:0002121) | 2.99393839 |
| 34 | Hypercortisolism (HP:0001578) | 2.98721916 |
| 35 | Gait imbalance (HP:0002141) | 2.88013976 |
| 36 | Epileptic encephalopathy (HP:0200134) | 2.87654046 |
| 37 | Spastic gait (HP:0002064) | 2.85716381 |
| 38 | Abnormal pancreas size (HP:0012094) | 2.85393171 |
| 39 | Generalized tonic-clonic seizures (HP:0002069) | 2.83905112 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.80048595 |
| 41 | Impaired pain sensation (HP:0007328) | 2.80009438 |
| 42 | Abnormality of pain sensation (HP:0010832) | 2.80009438 |
| 43 | Broad-based gait (HP:0002136) | 2.80008157 |
| 44 | Drooling (HP:0002307) | 2.79308042 |
| 45 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.75372285 |
| 46 | Truncal ataxia (HP:0002078) | 2.69769025 |
| 47 | Slow saccadic eye movements (HP:0000514) | 2.65818815 |
| 48 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.61601646 |
| 49 | Dialeptic seizures (HP:0011146) | 2.60030906 |
| 50 | Amblyopia (HP:0000646) | 2.59714955 |
| 51 | Status epilepticus (HP:0002133) | 2.57822876 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.56650316 |
| 53 | Abnormality of the musculature of the hand (HP:0001421) | 2.55419427 |
| 54 | Excessive salivation (HP:0003781) | 2.54602195 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.51939203 |
| 56 | Poor suck (HP:0002033) | 2.51316690 |
| 57 | Hypoventilation (HP:0002791) | 2.42386360 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.41708358 |
| 59 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.41158796 |
| 60 | Hypoplasia of the brainstem (HP:0002365) | 2.41158796 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.40019549 |
| 62 | Muscle stiffness (HP:0003552) | 2.39619339 |
| 63 | Spastic tetraplegia (HP:0002510) | 2.38788175 |
| 64 | Nephrogenic diabetes insipidus (HP:0009806) | 2.38517396 |
| 65 | Myotonia (HP:0002486) | 2.35757504 |
| 66 | Paraplegia (HP:0010550) | 2.29361935 |
| 67 | Insomnia (HP:0100785) | 2.28191895 |
| 68 | Scanning speech (HP:0002168) | 2.27389863 |
| 69 | Dysmetria (HP:0001310) | 2.25709798 |
| 70 | Peripheral hypomyelination (HP:0007182) | 2.25554295 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.24516986 |
| 72 | Anxiety (HP:0000739) | 2.22490301 |
| 73 | Depression (HP:0000716) | 2.22019165 |
| 74 | Lower limb muscle weakness (HP:0007340) | 2.21489813 |
| 75 | EEG with generalized epileptiform discharges (HP:0011198) | 2.21080569 |
| 76 | Vaginal atresia (HP:0000148) | 2.20447433 |
| 77 | Spastic paraplegia (HP:0001258) | 2.18207234 |
| 78 | Cerebral hypomyelination (HP:0006808) | 2.16776234 |
| 79 | Incomplete penetrance (HP:0003829) | 2.16317882 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 2.15224218 |
| 81 | Hypsarrhythmia (HP:0002521) | 2.14319241 |
| 82 | Genital tract atresia (HP:0001827) | 2.13411251 |
| 83 | Sleep apnea (HP:0010535) | 2.13005304 |
| 84 | Mutism (HP:0002300) | 2.12056743 |
| 85 | Anomalous pulmonary venous return (HP:0010772) | 2.11658673 |
| 86 | Anosmia (HP:0000458) | 2.10598351 |
| 87 | Growth hormone deficiency (HP:0000824) | 2.10413946 |
| 88 | Intention tremor (HP:0002080) | 2.10127186 |
| 89 | Cerebral hemorrhage (HP:0001342) | 2.10020830 |
| 90 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.08034670 |
| 91 | CNS hypomyelination (HP:0003429) | 2.07055528 |
| 92 | Neonatal hypoglycemia (HP:0001998) | 2.07046976 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.06888869 |
| 94 | Pes cavus (HP:0001761) | 2.04711003 |
| 95 | Torticollis (HP:0000473) | 2.04182149 |
| 96 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02647981 |
| 97 | Diplopia (HP:0000651) | 1.99722895 |
| 98 | Abnormality of binocular vision (HP:0011514) | 1.99722895 |
| 99 | Hyporeflexia of lower limbs (HP:0002600) | 1.99696475 |
| 100 | Specific learning disability (HP:0001328) | 1.97150588 |
| 101 | Progressive external ophthalmoplegia (HP:0000590) | 1.95862431 |
| 102 | Peripheral demyelination (HP:0011096) | 1.95842938 |
| 103 | Lissencephaly (HP:0001339) | 1.95170932 |
| 104 | Pachygyria (HP:0001302) | 1.94935476 |
| 105 | Abnormality of the labia minora (HP:0012880) | 1.94576261 |
| 106 | Gaze-evoked nystagmus (HP:0000640) | 1.94364255 |
| 107 | Postural instability (HP:0002172) | 1.94255940 |
| 108 | Metaphyseal dysplasia (HP:0100255) | 1.93979433 |
| 109 | Generalized hypotonia (HP:0001290) | 1.93748884 |
| 110 | Impaired vibratory sensation (HP:0002495) | 1.92740684 |
| 111 | Akinesia (HP:0002304) | 1.91671155 |
| 112 | Neurofibrillary tangles (HP:0002185) | 1.91523788 |
| 113 | Postural tremor (HP:0002174) | 1.91383695 |
| 114 | Diastasis recti (HP:0001540) | 1.90230980 |
| 115 | Annular pancreas (HP:0001734) | 1.88420233 |
| 116 | Rapidly progressive (HP:0003678) | 1.88221767 |
| 117 | Neoplasm of the adrenal cortex (HP:0100641) | 1.87992437 |
| 118 | Dysdiadochokinesis (HP:0002075) | 1.86898064 |
| 119 | Congenital malformation of the right heart (HP:0011723) | 1.86186931 |
| 120 | Double outlet right ventricle (HP:0001719) | 1.86186931 |
| 121 | Clonus (HP:0002169) | 1.85875920 |
| 122 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.85717139 |
| 123 | Hemiparesis (HP:0001269) | 1.85112686 |
| 124 | Agitation (HP:0000713) | 1.82886390 |
| 125 | Papilledema (HP:0001085) | 1.82744771 |
| 126 | Spastic tetraparesis (HP:0001285) | 1.82485860 |
| 127 | Facial shape deformation (HP:0011334) | 1.80942505 |
| 128 | Potter facies (HP:0002009) | 1.80942505 |
| 129 | Acute necrotizing encephalopathy (HP:0006965) | 1.80710246 |
| 130 | Progressive inability to walk (HP:0002505) | 1.80437163 |
| 131 | Slow progression (HP:0003677) | 1.80346069 |
| 132 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.80199384 |
| 133 | Cortical dysplasia (HP:0002539) | 1.79053289 |
| 134 | Craniofacial dystonia (HP:0012179) | 1.79001217 |
| 135 | Abnormality of the pulmonary veins (HP:0011718) | 1.78202407 |
| 136 | Hypoplasia of the corpus callosum (HP:0002079) | 1.76507578 |
| 137 | Abnormality of saccadic eye movements (HP:0000570) | 1.75864893 |
| 138 | Impaired smooth pursuit (HP:0007772) | 1.75456313 |
| 139 | Lower limb asymmetry (HP:0100559) | 1.74749851 |
| 140 | Focal dystonia (HP:0004373) | 1.74670323 |
| 141 | Impaired social interactions (HP:0000735) | 1.74296062 |
| 142 | Abnormal social behavior (HP:0012433) | 1.74296062 |
| 143 | Hyperthyroidism (HP:0000836) | 1.72829203 |
| 144 | Pointed chin (HP:0000307) | 1.72179363 |
| 145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.70473800 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.70473800 |
| 147 | Poor coordination (HP:0002370) | 1.69201810 |
| 148 | Dysautonomia (HP:0002459) | 1.68858136 |
| 149 | Hyperparathyroidism (HP:0000843) | 1.68216873 |
| 150 | Retinal dysplasia (HP:0007973) | 1.67668964 |
| 151 | Delusions (HP:0000746) | 1.67250269 |
| 152 | Bradykinesia (HP:0002067) | 1.67190195 |
| 153 | Bundle branch block (HP:0011710) | 1.66846737 |
| 154 | Molar tooth sign on MRI (HP:0002419) | 1.65200492 |
| 155 | Abnormality of midbrain morphology (HP:0002418) | 1.65200492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.63829690 |
| 2 | LMTK2 | 4.31484219 |
| 3 | MARK1 | 4.12516906 |
| 4 | MAP3K9 | 3.77838722 |
| 5 | MAP3K12 | 3.26027652 |
| 6 | * MINK1 | 3.22543724 |
| 7 | LATS2 | 3.20920659 |
| 8 | MAP3K4 | 2.89967190 |
| 9 | LIMK1 | 2.58463862 |
| 10 | MAP2K4 | 2.39738238 |
| 11 | WNK1 | 2.34113563 |
| 12 | KSR2 | 2.31473605 |
| 13 | PHKG2 | 2.29768698 |
| 14 | PHKG1 | 2.29768698 |
| 15 | MAP2K7 | 2.23308637 |
| 16 | NTRK1 | 2.15372377 |
| 17 | TYRO3 | 2.05155942 |
| 18 | PAK6 | 2.03499670 |
| 19 | RET | 1.68155635 |
| 20 | MAP3K2 | 1.53950141 |
| 21 | STK39 | 1.51461708 |
| 22 | WNK4 | 1.48215309 |
| 23 | CAMKK1 | 1.47545028 |
| 24 | BCR | 1.43697309 |
| 25 | SCYL2 | 1.41790008 |
| 26 | MAPK13 | 1.40582015 |
| 27 | NEK1 | 1.35419161 |
| 28 | STK38 | 1.25026451 |
| 29 | CDK5 | 1.24926833 |
| 30 | GRK5 | 1.21867409 |
| 31 | MAPKAPK3 | 1.18272975 |
| 32 | PRKCG | 1.15503900 |
| 33 | MAP3K11 | 1.09010476 |
| 34 | CDK19 | 1.05630855 |
| 35 | DYRK1A | 1.05197668 |
| 36 | CAMKK2 | 1.03075784 |
| 37 | CASK | 1.00181684 |
| 38 | CAMK1 | 0.98499413 |
| 39 | UHMK1 | 0.97427629 |
| 40 | CAMK1G | 0.95479241 |
| 41 | FER | 0.92731842 |
| 42 | BRAF | 0.90530282 |
| 43 | IRAK2 | 0.86857710 |
| 44 | PAK3 | 0.85772327 |
| 45 | CAMK2G | 0.85561576 |
| 46 | GRK7 | 0.84682612 |
| 47 | KSR1 | 0.84363812 |
| 48 | EPHA4 | 0.82641788 |
| 49 | ARAF | 0.82454094 |
| 50 | PNCK | 0.82247981 |
| 51 | MAP2K1 | 0.79193842 |
| 52 | DAPK2 | 0.79029043 |
| 53 | CAMK2A | 0.76904927 |
| 54 | ICK | 0.76803327 |
| 55 | STK16 | 0.76490527 |
| 56 | CDK14 | 0.76265273 |
| 57 | CDC42BPA | 0.75410490 |
| 58 | ADRBK2 | 0.75339870 |
| 59 | MAP3K1 | 0.74755106 |
| 60 | RPS6KA2 | 0.74462160 |
| 61 | RIPK4 | 0.73161325 |
| 62 | WNK3 | 0.71850585 |
| 63 | PRKD3 | 0.70954991 |
| 64 | SGK494 | 0.70800473 |
| 65 | SGK223 | 0.70800473 |
| 66 | DYRK1B | 0.69652829 |
| 67 | NTRK2 | 0.68260287 |
| 68 | PINK1 | 0.68065436 |
| 69 | EPHA3 | 0.66005811 |
| 70 | FES | 0.64182032 |
| 71 | CDK18 | 0.63938739 |
| 72 | CSNK1G3 | 0.63791747 |
| 73 | ADRBK1 | 0.63428801 |
| 74 | ROCK2 | 0.62153038 |
| 75 | PRKCZ | 0.61509872 |
| 76 | CDK15 | 0.61135941 |
| 77 | PLK2 | 0.60303283 |
| 78 | CAMK1D | 0.60039832 |
| 79 | EPHB2 | 0.59796028 |
| 80 | PDPK1 | 0.59251205 |
| 81 | SGK1 | 0.57710809 |
| 82 | CSNK1A1L | 0.57107866 |
| 83 | PKN1 | 0.55013908 |
| 84 | ERBB2 | 0.54848832 |
| 85 | DYRK3 | 0.52292107 |
| 86 | MATK | 0.52241883 |
| 87 | CDK11A | 0.52233031 |
| 88 | CSNK1G2 | 0.51864278 |
| 89 | FGFR2 | 0.51701603 |
| 90 | ALK | 0.51655599 |
| 91 | PDK1 | 0.51538045 |
| 92 | * PRKACA | 0.49663680 |
| 93 | ROCK1 | 0.49308066 |
| 94 | IRAK1 | 0.49235284 |
| 95 | PRKCE | 0.48588755 |
| 96 | PRKG1 | 0.47389292 |
| 97 | TNK2 | 0.46651471 |
| 98 | MAPK10 | 0.46606442 |
| 99 | PRKCH | 0.46595559 |
| 100 | TAOK1 | 0.43424997 |
| 101 | DAPK1 | 0.42940764 |
| 102 | TRIM28 | 0.41398491 |
| 103 | MAPK4 | 0.41384865 |
| 104 | CSNK1D | 0.41207182 |
| 105 | CSNK1G1 | 0.40798444 |
| 106 | * MAPK8 | 0.40677958 |
| 107 | BMPR1B | 0.39663746 |
| 108 | PRKACB | 0.39493181 |
| 109 | * CSNK1E | 0.38988634 |
| 110 | PRKDC | 0.38385188 |
| 111 | NME1 | 0.38263602 |
| 112 | STK11 | 0.37485088 |
| 113 | * GSK3B | 0.36854715 |
| 114 | SIK2 | 0.36792592 |
| 115 | MAPK9 | 0.36657690 |
| 116 | CAMK2B | 0.36531907 |
| 117 | OXSR1 | 0.36462909 |
| 118 | PRKCA | 0.36175933 |
| 119 | TNIK | 0.36000573 |
| 120 | FYN | 0.35675946 |
| 121 | CAMK2D | 0.35267556 |
| 122 | MARK2 | 0.32280266 |
| 123 | PRKG2 | 0.31708304 |
| 124 | AURKA | 0.31222096 |
| 125 | SGK2 | 0.29706611 |
| 126 | PTK2 | 0.29248736 |
| 127 | TESK1 | 0.29131512 |
| 128 | PDK3 | 0.29005939 |
| 129 | PDK4 | 0.29005939 |
| 130 | PRKCB | 0.28188331 |
| 131 | SGK3 | 0.26781062 |
| 132 | BRSK1 | 0.26631809 |
| 133 | RPS6KA3 | 0.25723352 |
| 134 | DYRK2 | 0.24645252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.14175668 |
| 2 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.14947433 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.01889518 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.41818352 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30375022 |
| 6 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.19885821 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.05727619 |
| 8 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.04198106 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.91556401 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.89102628 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.75966462 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.74104717 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73241936 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.71757635 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70023710 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69072580 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.67748202 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.66284453 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64884469 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64638084 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.61650372 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.56914881 |
| 23 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.52409995 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50500921 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49021685 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45611659 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41119792 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.37053860 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.36478874 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32800668 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32143519 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30804012 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24832470 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23049101 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17383841 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17048867 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16841954 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.16782540 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.16502556 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.15696186 |
| 41 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.14424714 |
| 42 | Ribosome_Homo sapiens_hsa03010 | 1.12176971 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12109677 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11329030 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11272540 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08306115 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.07081371 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05384010 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03875544 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02242906 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98763961 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98066719 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92502504 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89207481 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87986908 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87242075 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85551481 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85157250 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84678817 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.84296944 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80239160 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77747460 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76395372 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76188771 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75320980 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74804891 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69285401 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68598712 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.68579595 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.67995126 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.66082593 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.64987737 |
| 73 | Melanoma_Homo sapiens_hsa05218 | 0.64282060 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64100334 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.63674927 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63268841 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61753860 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.61269595 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60297795 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60119216 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58985554 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57474700 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57341372 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.56057119 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55838035 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55617214 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55415948 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54866016 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54782561 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52986158 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52045469 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51787614 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51313715 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50571068 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48813042 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48804855 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48370881 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47564717 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47543941 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47420922 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45267453 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43124485 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42767426 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42530600 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41080032 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40553613 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33556995 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33303719 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33294537 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31305538 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31203313 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29434889 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28465315 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28408078 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25117519 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24898845 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24851570 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23980852 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23038199 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22998161 |
| 121 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20543157 |

